Additional information regarding these results and other relevant information is included in the notes to the financial ...

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potenti ...

A centralized system with unprecedented access to data about Social Security, taxes, medical diagnoses and other private ...

The Independent Data Monitoring Committee recommended halting the Essential3 program for futility, but Praxis plans to continue the study to its completion, with results anticipated in the third ...

has received a recommendation to proceed without changes from the Independent Data Monitoring Committee. The trial is set to complete patient enrollment soon, with topline results anticipated by ...

The Independent Data Monitoring Committee recommended that the study be stopped for futility, due to the results being unlikely to meet the primary efficacy endpoint under the parameters set by ...

The Independent Data Monitoring Committee recommended halting the Essential3 program for futility, but Praxis plans to continue the study to its completion, with results anticipated in the third ...

The Swiss pharma said the decision was based on a review by the GENERATION HD1 study’s Independent Data Monitoring Committee. According to Roche the committee “made its recommendation based on ...

Akeso's HARMONi-6 Phase III clinical trial met its primary endpoint of progression-free survival at a prespecified interim analysis conducted by an independent data monitoring committee.

On February 28, Praxis shared the results of a pre-planned interim analysis of Study 1. The Independent Data Monitoring Committee recommended that the study be stopped for futility, due to the results ...

The independent data monitoring committee overseeing the study has recommended, however, that another phase 3 trial in patients called OCEANIC-STROKE continue as planned. That study is comparing ...